Giles Farley
InvestorCo-Head at ICU Ventures
About
Co-head of ICU Ventures leading Emerging Markets Fintech investments and a board member of Swiss pharmaceutical maker Synbias Pharma AG. His prior experience spans a Prague distressed real estate fund, ARTA Investment Partners in Kyiv, Citibank, Boston Consulting Group and a New York hedge fund. He holds an MBA from Stanford and a bachelor's degree from UCLA.